186 related articles for article (PubMed ID: 20469965)
21. Cholesterol in Niemann-Pick Type C disease.
Bi X; Liao G
Subcell Biochem; 2010; 51():319-35. PubMed ID: 20213549
[TBL] [Abstract][Full Text] [Related]
22. [Changes in the biosynthesis, esterification and efflux of cholesterol in fibroblasts in culture from patients with Niemann-Pick disease type C].
Mazière JC; Mazière C; Mora L; Lageron A; Polonovski C; Polonovski J
C R Seances Soc Biol Fil; 1986; 180(6):669-76. PubMed ID: 2952228
[TBL] [Abstract][Full Text] [Related]
23. Niemann-Pick type C disease: The atypical sphingolipidosis.
Newton J; Milstien S; Spiegel S
Adv Biol Regul; 2018 Dec; 70():82-88. PubMed ID: 30205942
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9-Mediated Generation of Niemann-Pick C1 Knockout Cell Line.
Du X; Lukmantara I; Yang H
Methods Mol Biol; 2017; 1583():73-83. PubMed ID: 28205168
[TBL] [Abstract][Full Text] [Related]
25. Impaired dynamics of the late endosome/lysosome compartment in human Niemann-Pick type C skin fibroblasts carrying mutation in NPC1 gene.
Sztolsztener ME; Dobrzyn A; Pikula S; Tylki-Szymanska A; Bandorowicz-Pikula J
Mol Biosyst; 2012 Apr; 8(4):1197-205. PubMed ID: 22286891
[TBL] [Abstract][Full Text] [Related]
26. Pathological cholesterol metabolism fails to modify electrophysiological properties of afflicted neurones in Niemann-Pick disease type C.
Deisz RA; Meske V; Treiber-Held S; Albert F; Ohm TG
Neuroscience; 2005; 130(4):867-73. PubMed ID: 15652985
[TBL] [Abstract][Full Text] [Related]
27. Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain.
Suzuki M; Sugimoto Y; Ohsaki Y; Ueno M; Kato S; Kitamura Y; Hosokawa H; Davies JP; Ioannou YA; Vanier MT; Ohno K; Ninomiya H
J Neurosci; 2007 Feb; 27(8):1879-91. PubMed ID: 17314284
[TBL] [Abstract][Full Text] [Related]
28. Niemann-Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2.
Verot L; Chikh K; Freydière E; Honoré R; Vanier MT; Millat G
Clin Genet; 2007 Apr; 71(4):320-30. PubMed ID: 17470133
[TBL] [Abstract][Full Text] [Related]
29. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease.
Lloyd-Evans E; Platt FM
Traffic; 2010 Apr; 11(4):419-28. PubMed ID: 20059748
[TBL] [Abstract][Full Text] [Related]
30. Niemann-Pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem Lewy bodies: an autopsy case.
Chiba Y; Komori H; Takei S; Hasegawa-Ishii S; Kawamura N; Adachi K; Nanba E; Hosokawa M; Enokido Y; Kouchi Z; Yoshida F; Shimada A
Neuropathology; 2014 Feb; 34(1):49-57. PubMed ID: 23711246
[TBL] [Abstract][Full Text] [Related]
31. δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disorders.
Xu M; Liu K; Swaroop M; Porter FD; Sidhu R; Firnkes S; Ory DS; Marugan JJ; Xiao J; Southall N; Pavan WJ; Davidson C; Walkley SU; Remaley AT; Baxa U; Sun W; McKew JC; Austin CP; Zheng W
J Biol Chem; 2012 Nov; 287(47):39349-60. PubMed ID: 23035117
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of an anti-tumor necrosis factor therapeutic in a mouse model of Niemann-Pick C liver disease.
Vincent M; Sayre NL; Graham MJ; Crooke RM; Shealy DJ; Liscum L
PLoS One; 2010 Sep; 5(9):e12941. PubMed ID: 20886067
[TBL] [Abstract][Full Text] [Related]
33. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
Maubert A; Hanon C; Metton JP
Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
[TBL] [Abstract][Full Text] [Related]
34. Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease.
Paron F; Dardis A; Buratti E
J Biotechnol; 2020 Jul; 318():20-30. PubMed ID: 32387451
[TBL] [Abstract][Full Text] [Related]
35. [Research advances in diagnosis and therapy of Niemann-Pick disease type C].
Ren SC; Gao BQ
Zhongguo Dang Dai Er Ke Za Zhi; 2015 May; 17(5):533-8. PubMed ID: 26014711
[TBL] [Abstract][Full Text] [Related]
36. Characterization of cholesterol homeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts reveals a Niemann-Pick disease type C-like phenotype with enhanced lysosomal Ca
Vienken H; Mabrouki N; Grabau K; Claas RF; Rudowski A; Schömel N; Pfeilschifter J; Lütjohann D; van Echten-Deckert G; Meyer Zu Heringdorf D
Sci Rep; 2017 Mar; 7():43575. PubMed ID: 28262793
[TBL] [Abstract][Full Text] [Related]
37. Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from non-neurologic Niemann-Pick type C patients but also patients possibly affected with other lipid trafficking disorders.
Harzer K; Massenkeil G; Fröhlich E
FEBS Lett; 2003 Feb; 537(1-3):177-81. PubMed ID: 12606053
[TBL] [Abstract][Full Text] [Related]
38. Activation of mammalian terget of rapamycin kinase and glycogen synthase kinase-3β accompanies abnormal accumulation of cholesterol in fibroblasts from Niemann-Pick type C patients.
Wos M; Komiażyk M; Pikula S; Tylki-Szymanska A; Bandorowicz-Pikula J
J Cell Biochem; 2019 Apr; 120(4):6580-6588. PubMed ID: 30390318
[TBL] [Abstract][Full Text] [Related]
39. The potential of histone deacetylase inhibitors in Niemann - Pick type C disease.
Maceyka M; Milstien S; Spiegel S
FEBS J; 2013 Dec; 280(24):6367-72. PubMed ID: 23992240
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of sphingomyelin in Niemann-Pick disease type C cells disrupts Rab9-dependent vesicular trafficking of cholesterol.
Wanikawa M; Nakamura H; Emori S; Hashimoto N; Murayama T
J Cell Physiol; 2020 Mar; 235(3):2300-2309. PubMed ID: 31489965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
